Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

od Gujar, Shashi, Pol, Jonathan G., Kroemer, Guido
izdano v Oncoimmunology (2018)

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin

od Pol, Jonathan G., Le Naour, Julie, Kroemer, Guido
izdano v Oncoimmunology (2020)

Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

od Gujar, Shashi, Pol, Jonathan G., Kim, Youra, Kroemer, Guido
izdano v Oncoimmunology (2020)

Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy

od Eriau, Erwan, Paillet, Juliette, Kroemer, Guido, Pol, Jonathan G.
izdano v Cancers (Basel) (2021)

Effects of interleukin-2 in immunostimulation and immunosuppression

od Pol, Jonathan G., Caudana, Pamela, Paillet, Juliette, Piaggio, Eliane, Kroemer, Guido
izdano v J Exp Med (2019)

Panorama From the Oncolytic Virotherapy Summit: 7th International Summit on Oncolytic Viral Therapeutics Quebec, Canada, 15–18 June 2013

od Pol, Jonathan G, Marguerie, Monique, Arulanandam, Rozanne, Bell, John C, Lichty, Brian D
Izdano 2013

Trial watch: dietary interventions for cancer therapy

od Lévesque, Sarah, Pol, Jonathan G., Ferrere, Gladys, Galluzzi, Lorenzo, Zitvogel, Laurence, Kroemer, Guido
izdano v Oncoimmunology (2019)

Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy

od Workenhe, Samuel T, Simmons, Graydon, Pol, Jonathan G, Lichty, Brian D, Halford, William P, Mossman, Karen L
Izdano 2014

Trial watch: DNA-based vaccines for oncological indications

od Pierini, Stefano, Perales-Linares, Renzo, Uribe-Herranz, Mireia, Pol, Jonathan G., Zitvogel, Laurence, Kroemer, Guido, Facciabene, Andrea, Galluzzi, Lorenzo
izdano v Oncoimmunology (2017)

Dynamical Boolean Modeling of Immunogenic Cell Death

od Checcoli, Andrea, Pol, Jonathan G., Naldi, Aurelien, Noel, Vincent, Barillot, Emmanuel, Kroemer, Guido, Thieffry, Denis, Calzone, Laurence, Stoll, Gautier
izdano v Front Physiol (2020)

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning

od Pol, Jonathan G, Atherton, Matthew J, Stephenson, Kyle B, Bridle, Byram W, Workenhe, Samuel T, Kazdhan, Natasha, McGray, AJ Robert, Wan, Yonghong, Kroemer, Guido, Lichty, Brian D
izdano v J Immunother Cancer (2020)

Maraba Virus as a Potent Oncolytic Vaccine Vector

od Pol, Jonathan G, Zhang, Liang, Bridle, Byram W, Stephenson, Kyle B, Rességuier, Julien, Hanson, Stephen, Chen, Lan, Kazdhan, Natasha, Bramson, Jonathan L, Stojdl, David F, Wan, Yonghong, Lichty, Brian D
Izdano 2014

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

od Lévesque, Sarah, Le Naour, Julie, Pietrocola, Federico, Paillet, Juliette, Kremer, Margerie, Castoldi, Francesca, Baracco, Elisa E., Wang, Yan, Vacchelli, Erika, Stoll, Gautier, Jolly, Ariane, De La Grange, Pierre, Zitvogel, Laurence, Kroemer, Guido, Pol, Jonathan G.
izdano v Oncoimmunology (2019)

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

od Pol, Jonathan G., Lévesque, Sarah, Workenhe, Samuel T., Gujar, Shashi, Le Boeuf, Fabrice, Clements, Derek R., Fahrner, Jean-Eudes, Fend, Laetitia, Bell, John C., Mossman, Karen L., Fucikova, Jitka, Spisek, Radek, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
izdano v Oncoimmunology (2018)

Development and applications of oncolytic Maraba virus vaccines

od Pol, Jonathan G, Atherton, Matthew J, Bridle, Byram W, Stephenson, Kyle B, Le Boeuf, Fabrice, Hummel, Jeff L, Martin, Chantal G, Pomoransky, Julia, Breitbach, Caroline J, Diallo, Jean-Simon, Stojdl, David F, Bell, John C, Wan, Yonghong, Lichty, Brian D
izdano v Oncolytic Virother (2018)

Autophagy-mediated metabolic effects of aspirin

od Castoldi, Francesca, Humeau, Juliette, Martins, Isabelle, Lachkar, Sylvie, Loew, Damarys, Dingli, Florent, Durand, Sylvère, Enot, David, Bossut, Noëlie, Chery, Alexis, Aprahamian, Fanny, Demont, Yohann, Opolon, Paule, Signolle, Nicolas, Sauvat, Allan, Semeraro, Michaela, Bezu, Lucillia, Baracco, Elisa Elena, Vacchelli, Erika, Pol, Jonathan G., Lévesque, Sarah, Bloy, Norma, Sica, Valentina, Maiuri, Maria Chiara, Kroemer, Guido, Pietrocola, Federico
izdano v Cell Death Discov (2020)

S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3

od Wang, Fuan, Alain, Tommy, Szretter, Kristy J., Stephenson, Kyle, Pol, Jonathan G., Atherton, Matthew J., Hoang, Huy-Dung, Fonseca, Bruno D., Zakaria, Chadi, Chen, Lan, Rangwala, Zainab, Hesch, Adam, Chan, Eva Sin Yan, Tuinman, Carly, Suthar, Mehul S., Jiang, Zhaozhao, Ashkar, Ali A., Thomas, George, Kozma, Sara C., Gale, Michael, Fitzgerald, Katherine A., Diamond, Michael S., Mossman, Karen, Sonenberg, Nahum, Wan, Yonghong, Lichty, Brian D.
izdano v Nat Immunol (2016)

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

od Buqué, Aitziber, Bloy, Norma, Perez-Lanzón, Maria, Iribarren, Kristina, Humeau, Juliette, Pol, Jonathan G., Levesque, Sarah, Mondragon, Laura, Yamazaki, Takahiro, Sato, Ai, Aranda, Fernando, Durand, Sylvère, Boissonnas, Alexandre, Fucikova, Jitka, Senovilla, Laura, Enot, David, Hensler, Michal, Kremer, Margerie, Stoll, Gautier, Hu, Yang, Massa, Chiara, Formenti, Silvia C., Seliger, Barbara, Elemento, Olivier, Spisek, Radek, André, Fabrice, Zitvogel, Laurence, Delaloge, Suzette, Kroemer, Guido, Galluzzi, Lorenzo
izdano v Nat Commun (2020)

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

od Buqué, Aitziber, Bloy, Norma, Perez-Lanzón, Maria, Iribarren, Kristina, Humeau, Juliette, Pol, Jonathan G., Levesque, Sarah, Mondragon, Laura, Yamazaki, Takahiro, Sato, Ai, Aranda, Fernando, Durand, Sylvère, Boissonnas, Alexandre, Fucikova, Jitka, Senovilla, Laura, Enot, David, Hensler, Michal, Kremer, Margerie, Stoll, Gautier, Hu, Yang, Massa, Chiara, Formenti, Silvia C., Seliger, Barbara, Elemento, Olivier, Spisek, Radek, André, Fabrice, Zitvogel, Laurence, Delaloge, Suzette, Kroemer, Guido, Galluzzi, Lorenzo
izdano v Nat Commun (2020)

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

od Pol, Jonathan G., Acuna, Sergio A., Yadollahi, Beta, Tang, Nan, Stephenson, Kyle B., Atherton, Matthew J., Hanwell, David, El-Warrak, Alexander, Goldstein, Alyssa, Moloo, Badru, Turner, Patricia V., Lopez, Roberto, LaFrance, Sandra, Evelegh, Carole, Denisova, Galina, Parsons, Robin, Millar, Jamie, Stoll, Gautier, Martin, Chantal G., Pomoransky, Julia, Breitbach, Caroline J., Bramson, Jonathan L., Bell, John C., Wan, Yonghong, Stojdl, David F., Lichty, Brian D., McCart, J. Andrea
izdano v Oncoimmunology (2018)